0001209191-18-052615.txt : 20180928 0001209191-18-052615.hdr.sgml : 20180928 20180928174351 ACCESSION NUMBER: 0001209191-18-052615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180927 FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hargreaves Glenn CENTRAL INDEX KEY: 0001554374 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37550 FILM NUMBER: 181095168 MAIL ADDRESS: STREET 1: 701 COOL SPRINGS BLVD CITY: FRANKLIN STATE: TN ZIP: 37067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quorum Health Corp CENTRAL INDEX KEY: 0001650445 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 474725208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1573 MALLORY LANE CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 615-221-1400 MAIL ADDRESS: STREET 1: 1573 MALLORY LANE CITY: BRENTWOOD STATE: TN ZIP: 37027 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-27 0 0001650445 Quorum Health Corp QHC 0001554374 Hargreaves Glenn 1573 MALLORY LANE SUITE 100 BRENTWOOD TN 37027 0 1 0 0 SVP & Chief Accounting Officer Common stock, par value $0.0001 per share 2018-09-27 4 J 0 75000 0.00 D 0 D Common stock, par value $0.0001 per share 2018-09-27 4 A 0 75000 0.00 A 75000 D On September 27, 2018, Quorum Health Corporation (the "Issuer") and the reporting person entered into an Acknowledgement of Award Cancellation cancelling the August 24, 2018 award of 75,000 shares of the Issuer's restricted common stock because it was issued in excess of the limitations under the Issuer's 2016 Stock Award Plan. Thereafter, the Issuer re-granted to the reporting person 75,000 shares of restricted common stock as an inducement award outside the Issuer's 2016 Stock Award Plan in reliance on the employment inducement exemption to shareholder approval provided under the New York Stock Exchange's Listed Company Manual Rule 303A.08. 50% of the award is time-vested restricted stock and vests in three equal installments beginning on the first anniversary of August 24, 2018, and 50% of the award is performance-based restricted common stock and vests, if at all, over a two-year performance period based on the achievement of target metrics. /s/ R. Harold McCard, Jr., Attorney in Fact for Glenn Hargreaves 2018-09-28